News & Perspective

Dec 31, 2012

Dec 31, 2012

FDA approves first med for multidrug-resistant TB

(CIDRAP News) – The US Food and Drug Administration (FDA) today announced its approval of Sirturo (bedaquiline), the first drug developed specifically to treat multidrug-resistant tuberculosis (MDR-TB), saying it must be used in combination with other TB medications.

Dec 20, 2012

Dec 20, 2012

Attack rate in fungal meningitis outbreak estimated at 4.4%

(CIDRAP News) – Researchers estimate from preliminary data that 4.4% of patients who were exposed to contaminated steroid drugs from a Massachusetts compounding pharmacy contracted fungal meningitis or other fungal infections, according to a new report in the New England Journal of Medicine.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»